Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

被引:0
|
作者
Noel Pabalan
Ofelia Francisco-Pabalan
Lillian Sung
Hamdi Jarjanazi
Hilmi Ozcelik
机构
[1] Saint Louis University,College of Natural Sciences
[2] University Health Network,Analytical Genetics Technology Centre, Princess Margaret Hospital
[3] Hospital for Sick Children,Division of Hematology/Oncology
[4] Ontario Ministry of the Environment,Environmental Monitoring and Reporting Branch
[5] Mount Sinai Hospital,Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute
来源
Breast Cancer Research and Treatment | 2010年 / 124卷
关键词
Breast cancer; ERCC2; XPD; Asp312Asn; Lys751Gln; Adducts;
D O I
暂无
中图分类号
学科分类号
摘要
The excision repair cross-complementing group 2 gene (ERCC2) plays a key role in DNA repair. Several polymorphisms in the ERCC2 gene have been described, including the commonly occurring Lys751Gln and Asp312Asn polymorphisms. Studies investigating the association of these polymorphisms with breast cancer risk produced controversial results. To evaluate these associations presented in diverse populations, we have conducted a meta-analysis based on 40 studies from 33 publications in PubMed which included analyses of Lys751Gln (14,545 cases, 15,352 controls) and Asp312Asn polymorphisms (16,254 cases, 14,006 controls). Overall findings of both polymorphisms have implicated null effects (OR = 1.01–1.03) when the analyses were limited to the statistically powerful (≥80%) studies. Although modestly increased statistically significant breast cancer risk was detected in the underpowered studies (≤80%), removal of outliers resulted in null associations. Ethnic stratification showed non-significant and relatively null associations for both polymorphisms with breast cancer risk for the overall Caucasians as well as North American and the European sub-populations. Although statistically increased and decreased risks were observed for the homogenous populations of African-Americans (Lys751Gln, OR 1.25, 95% CI 1.03–1.53, P = 0.03) and Asians (Asp312Asn, ORs: 0.53–0.55, P values: 0.02–0.03), respectively, this may be the result of small sample size. Analyses of the homogeneous adduct studies, with relatively large sample size, exhibited increased risk for Lys751Gln (OR 1.20, 95% CI (1.02–1.41), P = 0.03) and Asp312Asn (OR 1.17 95% CI 1.02–1.34, P = 0.03) under the dominant genetic model. In conclusion, our results suggest null associations of both polymorphisms in the overall and the Caucasian subgroups, although some effects can be suggested for relatively smaller minority studies. Increased risk effect was more visible when the adduct studies are considered, suggesting the role of these polymorphisms in the presence of exposure to DNA damaging agents.
引用
收藏
页码:531 / 541
页数:10
相关论文
共 50 条
  • [21] XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population
    Yang, Qi
    Wei, Yan-Fei
    Zhang, Yuan
    Huang, Guang-Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2406 - 2414
  • [22] Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: A systematic review and meta-analysis
    Ma, Qingtong
    Qi, Can
    Tie, Chong
    Guo, Zhanjun
    GENE, 2013, 530 (02) : 309 - 314
  • [23] XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer
    Hansen, Rikke Dalgaard
    Sorensen, Mette
    Tjonneland, Anne
    Overvad, Kim
    Wallin, Hakan
    Raaschou-Nielsen, Ole
    Vogel, Ulla
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2007, 619 (1-2) : 68 - 80
  • [24] A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population
    Yin, Jiaoyang
    Vogel, Ulla
    Ma, Yegang
    Qi, Rong
    Sun, Zhongfu
    Wang, Huiwen
    CANCER GENETICS AND CYTOGENETICS, 2007, 175 (01) : 47 - 51
  • [25] XPD Lys751Gln Polymorphisms and the Risk of Esophageal Cancer: An Updated Meta-Analysis
    Guo, Xu-Feng
    Wang, Jun
    Lei, Xiao-Fei
    Zeng, Yan-Ping
    Dong, Wei-Guo
    INTERNAL MEDICINE, 2015, 54 (03) : 251 - 259
  • [26] XPA A23G, XPC Lys939GIn, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking and dietary factors, and risk of colorectal cancer
    Hansen, Rikke Dalgaard
    Sorensen, Mette
    Tjonneland, Anne
    Overvad, Kim
    Raaschou-Nielsen, Ole
    Vogel, Ulla
    TOXICOLOGY LETTERS, 2006, 164 : S259 - S260
  • [27] The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: A systematic review and meta-analysis
    Liu, Duo
    Wu, Dongyuan
    Li, Hongbin
    Dong, Mei
    GENE, 2014, 538 (02) : 209 - 216
  • [28] XPD Asp312Asn、Lys751Gln基因多态性与铅毒性易感性关系
    刘祥铨
    张忠
    吴京颖
    王志勇
    何颖荣
    刘合焜
    中国职业医学, 2013, 40 (02) : 128 - 130+134
  • [29] Association of ERCC1 C8092A and ERCC2 Lys751Gln Polymorphisms with the Risk of Glioma: A Meta-Analysis
    Xin, Yu
    Hao, Shuyu
    Lu, Jiapeng
    Wang, Qianyi
    Zhang, Liwei
    PLOS ONE, 2014, 9 (04):
  • [30] Predictive value of excision repair cross-complementing group 2 gene Lys751Gln and Asp312Asn polymorphisms in melanoma risk
    Zhou, Xue
    Zeng, Yong
    Jiang, Huayong
    Xia, Limei
    Liu, Chuan
    MELANOMA RESEARCH, 2018, 28 (04) : 311 - 318